药物对纤维过敏性肺炎肺功能的影响
Takemoto Abe1, Tsukasa Okamoto2, Takashi Shimamura3
1Department of Respiratory Medicine, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
Respiratory investigation
|September 11, 2025
概括
系统性疗法,如葡萄糖皮质类药物和抗纤维素药物显著减缓纤维素过敏性肺炎 (HP) 的肺功能下降. 这项研究表明,与未接受治疗的人相比,接受治疗的患者每年强迫生命能力 (FVC) 的下降减少.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 过敏性肺炎 (HP) 管理往往需要超越抗原回避的全身疗法.
- 葡萄糖皮质类药物,免疫抑制剂和抗纤维素药物对纤维化HP患者肺功能的疗效尚未得到充分证实.
- 纤维性HP需要了解治疗对肺功能的影响,以改善患者的治疗结果.
研究的目的:
- 评估全身疗法对纤维过敏性肺炎患者肺功能的影响.
- 分析治疗开始前后肺功能的纵向变化.
- 为了比较治疗和未治疗患者的强迫生命能力 (FVC) 衰退的速度.
主要方法:
- 回顾性队列研究分析了388名患者的肺功能数据.
- 使用线性混合效应模型和中断时间序列分析来评估肺功能的变化.
- 多变量回归分析根据年龄,性别和吸烟史进行调整.
主要成果:
- 预计FVC百分比的年度整体下降率为3.16%.
- 与整体队列相比,未接受治疗的患者的衰退速度较慢 (1.68%/年).
- 系统疗法显著减少了FVC的年度下降:从治疗后的6.96%降至3.03%.
- 单独使用葡萄糖皮质类药物,每年从6.96%降低到0.32%.
- 抗纤维素药物减缓了这种下降,从每年4.24%降至1.24%.
结论:
- 系统性疗法,特别是葡萄皮质类药物和抗纤维素药物,大大减缓了纤维化HP的FVC下降.
- 这些发现强调了特定的全身治疗在控制纤维化HP进展方面的好处.
- 建议进行进一步的前性试验,以验证这些回顾性发现.
相关概念视频
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.1K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
741
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
741
01:23Inhaled Medications
756
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
756
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:25Pulmonary Function Tests
758
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
758